Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Chrystal M. Paulos, … , Steven A. Rosenberg, Nicholas P. Restifo
Chrystal M. Paulos, … , Steven A. Rosenberg, Nicholas P. Restifo
Published August 1, 2007
Citation Information: J Clin Invest. 2007;117(8):2197-2204. https://doi.org/10.1172/JCI32205.
View: Text | PDF | Corrigendum
Research Article Oncology Article has an altmetric score of 33

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling

  • Text
  • PDF
Abstract

Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8+ T cells by depleting inhibitory lymphocytes and increasing homeostatic cytokine levels. We found that TBI augmented the function of adoptively transferred CD8+ T cells in mice genetically deficient in all lymphocytes, indicating the existence of another TBI mechanism of action. Additional investigation revealed commensal gut microflora in the mesenteric lymph nodes and elevated LPS levels in the sera of irradiated mice. These findings correlated with increased dendritic cell activation and heightened levels of systemic inflammatory cytokines. Reduction of host microflora using antibiotics, neutralization of serum LPS using polymyxin B, or removal of LPS signaling components using mice genetically deficient in CD14 and TLR4 reduced the beneficial effects of TBI on tumor regression. Conversely, administration of microbial ligand–containing serum or ultrapure LPS from irradiated animals to nonirradiated antibody-lymphodepleted mice enhanced CD8+ T cell activation and improved tumor regression. Administration of ultrapure LPS to irradiated animals further enhanced the number and function of the adoptively transferred cells, leading to long-term cure of mice with large B16F10 tumors and enhanced autoimmune vitiligo. Thus, disruption of the homeostatic balance between the host and microbes can enhance cell-based tumor immunotherapy.

Authors

Chrystal M. Paulos, Claudia Wrzesinski, Andrew Kaiser,, Christian S. Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C. Palmer, Andrea Boni, Pawel Muranski, Zhiya Yu, Luca Gattinoni, Paul A. Antony, Steven A. Rosenberg, Nicholas P. Restifo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Total
Citations: 7 25 27 27 31 25 19 10 18 12 21 16 10 16 8 14 17 13 1 317
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (317)

Title and authors Publication Year
Tumor microbiome: roles in tumor initiation, progression, and therapy
Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y
Molecular Biomedicine 2025
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Sun J, Song S, Liu J, Chen F, Li X, Wu G
NPJ Biofilms and Microbiomes 2025
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Liu Y, Li F, Wang J, Yang R
Frontiers in Immunology 2025
Microbiota-Derived L-SeMet Potentiates CD8+ T Cell Effector Functions and Facilitates Anti-Tumor Responses
Fan S, Li Y, Huang S, Wang W, Zhang B, Zhang J, Jian X, Song Z, Wu M, Tu H, Wen Y, Li H, Li S, Hu H
International Journal of Molecular Sciences 2025
Exploring the Microbiome’s Impact on Glioma and Brain Metastases: Insights into Development, Progression, and Treatment Response—A Scoping Review
Leigh J, Skidmore B, Wong A, Maleki Vareki S, Ng TL
Cancers 2025
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
Huang M, Ji Q, Huang H, Wang X, Wang L
Gut Microbes 2025
Immunoenhancing of the anti-cancer therapy and anti-oxidative stress by co-administration of granulocyte-colony stimulating factor-mobilized stem cells or cells derived from bone marrow and/or spleen plus vaccination with chemotherapeutic cyclophosphamide.
Gomaa S, Nassef M, Tabl G, Gabry SE
Immunologic research 2025
Infection of tumor cells with Salmonella typhimurium mimics immunogenic cell death and elicits tumor-specific immune responses
Horiuchi Y, Nakamura A, Imai T, Murakami T
2024
Oral administration of Manuka honey induces IFNγ-dependent resistance to tumor growth that correlates with beneficial modulation of gut microbiota composition
Masad RJ, Idriss I, Mohamed YA, Al-Sbiei A, Bashir G, Al-Marzooq F, Altahrawi A, Fernandez-Cabezudo MJ, Al-Ramadi BK
Frontiers in immunology 2024
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Cavalluzzo B, Viuff MC, Tvingsholm SA, Ragone C, Manolio C, Mauriello A, Buonaguro FM, Tornesello ML, Izzo F, Morabito A, Hadrup SR, Tagliamonte M, Buonaguro L
Journal of experimental & clinical cancer research : CR 2024
Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?
Zhang PF, Xie D
Frontiers in immunology 2024
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Golonko A, Pienkowski T, Swislocka R, Orzechowska S, Marszalek K, Szczerbinski L, Swiergiel AH, Lewandowski W
Cell Death and Disease 2024
Influence of Microbiota on Tumor Immunotherapy
Yu X, Li W, Li Z, Wu Q, Sun S
International journal of biological sciences 2024
Critical role of the gut microbiota in immune responses and cancer immunotherapy.
Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kołat D, Li X, Zhou D, Xu X, Zhao L
Journal of Hematology & Oncology 2024
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review.
Sang Y, Zheng K, Zhao Y, Liu Y, Zhu S, Xie X, Shang L, Liu J, Li L
Translational cancer research 2024
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma.
Inukai Y, Yamamoto K, Honda T, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Ishigami M, Kawashima H
Cancers 2024
Gastric Cancer, Immunotherapy, and Nutrition: The Role of Microbiota
Raoul P, De Gaetano V, Sciaraffia G, Ormea G, Cintoni M, Pozzo C, Strippoli A, Gasbarrini A, Mele MC, Rinninella E
Pathogens 2024
Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers
Profir M, Roşu OA, Creţoiu SM, Gaspar BS
Microorganisms 2024
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X, Tang H, Xie X, Wu M, Zou Y
iMeta 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Wittling MC, Knochelmann HM, Wyatt MM, Rangel Rivera GO, Cole AC, Lesinski GB, Paulos CM
Journal for ImmunoTherapy of Cancer 2024
Disruption of post-thymic tolerance in skin-reactive TCR transgenic mice through the interaction of lymphopenia and intestinal microbiota
Hayabuchi H, Tokifuji Y, Takahashi H, Amagai M, Yoshimura A, Chikuma S
International Immunology 2024
Gut dysbiosis impacts the immune system and promotes prostate cancer
Shyanti RK, Greggs J, Malik S, Mishra M
Immunology Letters 2024
Strategies for Improving CAR T Cell Persistence in Solid Tumors
Wittling MC, Cole AC, Brammer B, Diatikar KG, Schmitt NC, Paulos CM
Cancers 2024
Global research trends on the links between gut microbiota and radiotherapy: a bibliometric analysis (2004-2023).
Wang S, Yuan Z, Gao X, Wu J, Ren Y, Yu X, Li J, Wei W
Frontiers in cellular and infection microbiology 2024
Dissecting the causal links between gut microbiome, immune traits and polyp using genetic evidence
Zhou C, Ye X, Liu Z, Liu T, Li S, Yang J, Wei J, Yu P, Jia R, Zhao W
Frontiers in Immunology 2024
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium
Nandi D, Sharma D
Frontiers in Immunology 2024
Understanding the relationship between breast cancer, immune checkpoint inhibitors, and gut microbiota: a narrative review
Hrubesz G, Leigh J, Ng TL
Translational Breast Cancer Research 2024
Therapeutic potential of Parabacteroides distasonis in gastrointestinal and hepatic disease
Duan J, Li Q, Cheng Y, Zhu W, Liu H, Li F
MedComm 2024
Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies
Farhadi Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M, Alibabaei F, Banihashemian SZ, Oksenych V, Eslami M
Biomedicines 2024
Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration
Trisal A, Singh I, Garg G, Jorwal K, Singh AK
3 Biotech 2024
Colorectal cancer and microbiota: systematic review
Imanbayev N, Iztleuov Y, Bekmukhambetov Y, Abdelazim IA, Donayeva A, Amanzholkyzy A, Aigul Z, Aigerim I, Aslan Y
Przegla̜d Gastroenterologiczny 2024
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Xie J, Smith M
Blood 2024
Hedgehog activity regulates a metabolic program of Treg to Th17 conversion in breast cancer
Dominique Hinshaw, Gloria Benavides, Brandon Metge, Courtney Swain, Sarah Kammerud, Heba Alsheikh, Amr Elhamamsy, Dongquan Chen, Victor Darley-Usmar, Jeffrey Rathmell, Robert Welner, Rajeev Samant, Lalita Shevde
Cancer immunology research 2023
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Álvarez-Mercado AI, del Valle Cano A, Fernández MF, Fontana L
Cancers 2023
Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
Lopes S, Pabst L, Dory A, Klotz M, Gourieux B, Michel B, Mascaux C
Frontiers in immunology 2023
CAR-T Cell Therapy and the Gut Microbiota
Asokan S, Cullin N, Stein-Thoeringer CK, Elinav E
Cancers 2023
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Mohseni AH, Taghinezhad-S S, Casolaro V, Lv Z, Li D
Cell Death and Disease 2023
The role of the sex hormone-gut microbiome axis in tumor immunotherapy
Wang L, Tang L, Zhai D, Song M, Li W, Xu S, Jiang S, Meng H, Liang J, Wang Y, Zhang B
Gut microbes 2023
The Interaction between Gut Microbiota and Host Amino Acids Metabolism in Multiple Myeloma
Yang Q, Wei Y, Zhu Y, Guo J, Zhang J, He Y, Li X, Liu J, Zhou W
Cancers 2023
Diet-gut microbial interactions influence cancer immunotherapy.
Wang X, Geng S
Frontiers in Oncology 2023
Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
Pabst L, Lopes S, Bertrand B, Creusot Q, Kotovskaya M, Pencreach E, Beau-Faller M, Mascaux C
International journal of molecular sciences 2023
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome
Shah H, Ng TL
Translational Lung Cancer Research 2023
Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A, Alexander SG, Martin S
Frontiers in immunology 2023
Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors.
Brightman SE, Becker A, Thota RR, Naradikian MS, Chihab L, Zavala KS, Griswold RQ, Dolina JS, Cohen EEW, Miller AM, Peters B, Schoenberger SP
Nature Immunology 2023
Enhancing therapeutic effects of murine cancer vaccine by reshaping gut microbiota with Lactobacillus rhamnosus GG and jujube powder.
Jing N, Wang L, Zhuang H, Jiang G, Liu Z
Frontiers in immunology 2023
Liver in infections: a single-cell and spatial transcriptomics perspective
Zou J, Li J, Zhong X, Tang D, Fan X, Chen R
Journal of biomedical science 2023
Gut and urinary microbiota: the causes and potential treatment measures of renal cell carcinoma
Yang JW, Wan S, Li KP, Chen SY, Yang L
Frontiers in immunology 2023
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
Mendes I, Vale N
International journal of molecular sciences 2023
Yeast culture supplementation of sow diets regulates the immune performance of their weaned piglets under lipopolysaccharide stress
Liu Y, Jia X, Chang J, Pan X, Jiang X, Che L, Lin Y, Zhuo Y, Feng B, Fang Z, Li J, Hua L, Wang J, Sun M, Wu D, Xu S
Journal of animal science 2023
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue X, Li R, Chen Z, Li G, Liu B, Guo S, Yue Q, Yang S, Xie L, Zhang Y, Zhao J, Tan R
Frontiers in immunology 2023
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy
Staudt S, Ziegler-Martin K, Visekruna A, Slingerland J, Shouval R, Hudecek M, van den Brink M, Luu M
Frontiers in immunology 2023
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome.
Klebanoff CA, Chandran SS, Baker BM, Quezada SA, Ribas A
Nature reviews. Drug discovery 2023
Microbiota in cancer: molecular mechanisms and therapeutic interventions
Chen Z, Guan D, Wang Z, Li X, Dong S, Huang J, Zhou W
2023
Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity
Giambra V, Pagliari D, Rio P, Totti B, Di Nunzio C, Bosi A, Giaroni C, Gasbarrini A, Gambassi G, Cianci R
Cells 2023
Association of Age-Related Macular Degeneration with a Blood Biomarker of Lipopolysaccharide, a Gut Bacterial Proinflammatory Toxin.
Larsen PP, Féart C, Pais de Barros JP, Merle BMJ, Gayraud L, Delyfer MN, Korobelnik JF, Delcourt C
Investigative ophthalmology & visual science 2023
Microbiota: A key factor affecting and regulating the efficacy of immunotherapy
Jiang Y, Jia D, Sun Y, Ding N, Wang L
Clinical and Translational Medicine 2023
Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
Lickefett B, Chu L, Ortiz-Maldonado V, Warmuth L, Barba P, Doglio M, Henderson D, Hudecek M, Kremer A, Markman J, Nauerth M, Negre H, Sanges C, Staber PB, Tanzi R, Delgado J, Busch DH, Kuball J, Luu M, Jäger U
Frontiers in immunology 2023
Melanoma and microbiota: Current understanding and future directions
Routy B, Jackson T, Mählmann L, Baumgartner CK, Blaser M, Byrd A, Corvaia N, Couts K, Davar D, Derosa L, Hang HC, Hospers G, Isaksen M, Kroemer G, Malard F, McCoy KD, Meisel M, Pal S, Ronai Z, Segal E, Sepich-Poore GD, Shaikh F, Sweis RF, Trinchieri G, van den Brink M, Weersma RK, Whiteson K, Zhao L, McQuade J, Zarour H, Zitvogel L
Cancer Cell 2023
How do tumours outside the gastrointestinal tract respond to dietary fibre supplementation?
Asim F, Clarke L, Donnelly E, Jamal FR, Piccicacchi LM, Qadir M, Raja NT, Samadi C, Then CK, Kiltie AE
BMJ Oncology 2023
Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention
W Zhang, J Zhang, T Liu, J Xing, H Zhang, D Wang, D Tang
Journal of Cancer Research and Clinical Oncology 2022
B cells imprint adoptively transferred CD8 + T cells with enhanced tumor immunity
A Smith, H Knochelmann, M Wyatt, G Rivera, A Rivera-Reyes, C Dwyer, M Ware, A Cole, D Neskey, M Rubinstein, B Liu, J Thaxton, E Bartee, C Paulos
Journal for ImmunoTherapy of Cancer 2022
The Microbiome: the Link to Colorectal Cancer and Research Opportunities
S Cass, N Ajami, M White
Current Treatment Options in Oncology 2022
Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation
M Pianko, J Golob
Cancer and Metastasis Reviews 2022
Role-Playing Between Environmental Pollutants and Human Gut Microbiota: A Complex Bidirectional Interaction.
Giambò F, Costa C, Teodoro M, Fenga C
Frontiers in Medicine 2022
Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas
You L, Zhou J, Xin Z, Hauck JS, Na F, Tang J, Zhou X, Lei Z, Ying B
2022
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Lu Y, Yuan X, Wang M, He Z, Li H, Wang J, Li Q
Journal of Hematology & Oncology 2022
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, Hasanpoor Z, Zadeh FA, Kahrizi MS
Journal of Translational Medicine 2022
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Ragone C, Manolio C, Mauriello A, Cavalluzzo B, Buonaguro FM, Tornesello ML, Tagliamonte M, Buonaguro L
Journal of Translational Medicine 2022
Gut microbiome in modulating immune checkpoint inhibitors
Li X, Zhang S, Guo G, Han J, Yu J
EBioMedicine 2022
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab
Martini G, Ciardiello D, Dallio M, Famiglietti V, Esposito L, Corte CM, Napolitano S, Fasano M, Gravina AG, Romano M, Loguercio C, Federico A, Maiello E, Tuccillo C, Morgillo F, Troiani T, Di Maio M, Martinelli E, Ciardiello F
International Journal of Cancer 2022
Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review
Li M, Zheng Y, Zhao J, Liu M, Shu X, Li Q, Wang Y, Zhou Y
Current Oncology 2022
Targeting the gut microbiota for cancer therapy.
Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G
Nature reviews. Cancer 2022
Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases.
Vivarelli S, Costa C, Teodoro M, Giambò F, Tsatsakis AM, Fenga C
Archives of Toxicology 2022
Anti-cancer activity of human gastrointestinal bacteria.
Quazi S
Medical Oncology 2022
Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
He Y, Huang J, Li Q, Xia W, Zhang C, Liu Z, Xiao J, Yi Z, Deng H, Xiao Z, Hu J, Li H, Zu X, Quan C, Chen J
Cancers 2022
The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors.
Wu Z, Zhang S, Li L, Huang Z, Huang D, Hu Y
Frontiers in Oncology 2022
The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host.
Huang JT, Mao YQ
Frontiers in Oncology 2022
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E
World journal of clinical oncology 2022
The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments
Son YM, Kim J
Journal of Microbiology and Biotechnology 2022
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
Zhang L, Xiang Y, Li Y, Zhang J
Frontiers in immunology 2022
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
Grenda A, Iwan E, Krawczyk P, Frąk M, Chmielewska I, Bomba A, Giza A, Rolska-Kopińska A, Szczyrek M, Kieszko R, Kucharczyk T, Jarosz B, Wasyl D, Milanowski J
Cancers 2022
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Karasarides M, Cogdill AP, Robbins PB, Bowden M, Burton EM, Butterfield LH, Cesano A, Hammer C, Haymaker CL, Horak CE, McGee HM, Monette A, Rudqvist NP, Spencer CN, Sweis RF, Vincent BG, Wennerberg E, Yuan J, Zappasodi R, Lucey VM, Wells DK, LaVallee T
Cancer immunology research 2022
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy.
Davar D, Zarour HM
Clinical cancer research 2022
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer
Li Z, Ke X, Zuo D, Wang Z, Fang F, Li B
Nutrients 2022
Perturbation of the Gut Microbiome and Association with Outcomes Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
D\u2019Angelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, Callander N
Leukemia & Lymphoma 2022
Microbiome as an immune regulator in health, disease, and therapeutics.
Juarez VM, Montalbine AN, Singh A
Advanced Drug Delivery Reviews 2022
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
S Chandrasekaran, CR Funk, T Kleber, CM Paulos, M Shanmugam, EK Waller
Frontiers in immunology 2021
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
Y Bouferraa, A Chedid, G Amhaz, AE Lakkiss, D Mukherji, S Temraz, A Shamseddine
International journal of molecular sciences 2021
The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation
LT Khuat, M Dave, WJ Murphy
Gut microbes 2021
The Microbiome and Its Implications in Cancer Immunotherapy
H Choudhry
Molecules (Basel, Switzerland) 2021
The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy
ML Schubert, R Rohrbach, M Schmitt, CK Stein-Thoeringer
Frontiers in immunology 2021
An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model
K Kitagawa, M Tatsumi, M Kato, S Komai, H Doi, Y Hashii, T Katayama, M Fujisawa, T Shirakawa
Molecular Therapy — Oncolytics 2021
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
S Lesch, V Blumenberg, S Stoiber, A Gottschlich, J Ogonek, BL Cadilha, Z Dantes, F Rataj, K Dorman, J Lutz, CH Karches, C Heise, M Kurzay, BM Larimer, S Grassmann, M Rapp, A Nottebrock, S Kruger, N Tokarew, P Metzger, C Hoerth, MR Benmebarek, D Dhoqina, R Grünmeier, M Seifert, A Oener, Ö Umut, S Joaquina, L Vimeux, T Tran, T Hank, T Baba, D Huynh, RT Megens, KP Janssen, M Jastroch, D Lamp, S Ruehland, MD Pilato, JN Pruessmann, M Thomas, C Marr, S Ormanns, A Reischer, M Hristov, E Tartour, E Donnadieu, S Rothenfusser, P Duewell, LM König, M Schnurr, M Subklewe, AS Liss, N Halama, M Reichert, TR Mempel, S Endres, S Kobold
Nature Biomedical Engineering 2021
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
A Kumar, R Watkins, AE Vilgelm
Frontiers in immunology 2021
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
T Jain, P Sharma, AC Are, SM Vickers, V Dudeja
Frontiers in immunology 2021
The microbiome and human cancer
GD Sepich-Poore, L Zitvogel, R Straussman, J Hasty, JA Wargo, R Knight
Science 2021
Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy
P Cheng, P Shen, Y Shan, Y Yang, R Deng, W Chen, Y Lu, Z Wei
Frontiers in Cell and Developmental Biology 2021
Acute Radiation Syndrome and the Microbiome: Impact and Review
BA Hollingsworth, DR Cassatt, AL DiCarlo, CI Rios, MM Satyamitra, TA Winters, LP Taliaferro
Frontiers in pharmacology 2021
Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
VL Noci, G Bernardo, F Bianchi, E Tagliabue, M Sommariva, L Sfondrini
Frontiers in Cell and Developmental Biology 2021
Gut microbiota: impacts on gastrointestinal cancer immunotherapy
HC Lau, JJ Sung, J Yu
Gut microbes 2021
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
N Khan, S Lindner, AL Gomes, SM Devlin, GL Shah, AD Sung, CS Sauter, HJ Landau, PB Dahi, MA Perales, DJ Chung, AM Lesokhin, A Dai, A Clurman, JB Slingerland, AE Slingerland, DG Brereton, PA Giardina, M Maloy, GK Armijo, C Rondon-Clavo, E Fontana, L Bohannon, S Ramalingam, AT Bush, MV Lew, JA Messina, E Littmann, Y Taur, RR Jenq, NJ Chao, S Giralt, KA Markey, EG Pamer, MR van den Brink, JU Peled
Blood 2021
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
KC Lam, RE Araya, A Huang, Q Chen, MD Modica, RR Rodrigues, A Lopès, SB Johnson, B Schwarz, E Bohrnsen, AP Cogdill, CM Bosio, JA Wargo, MP Lee, RS Goldszmid
Cell 2021
Increase in Akkermansiaceae in Gut Microbiota of Prostate Cancer-Bearing Mice
PY Huang, YC Yang, CI Wang, PW Hsiao, HI Chiang, TW Chen
International journal of molecular sciences 2021
Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy
J Chau, J Zhang
International journal of molecular sciences 2021
Melatonin and Cancer: A Polyhedral Network Where the Source Matters
MA Bonmati-Carrion, A Tomas-Loba
Antioxidants 2021
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
L Lione, E Salvatori, A Petrazzuolo, A Massacci, R Maggio, A Conforti, M Compagnone, L Aurisicchio, G Ciliberto, F Palombo
OncoImmunology 2021
Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
V Matson, CS Chervin, TF Gajewski
Gastroenterology 2021
Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy
D Yang, X Wang, X Zhou, J Zhao, H Yang, S Wang, MA Morse, J Wu, Y Yuan, S Li, A Hobeika, HK Lyerly, J Ren
OncoImmunology 2021
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment – Chance or Curse?
A Smet, J Kupcinskas, A Link, G Hold, J Bornschein
CMGH Cellular and Molecular Gastroenterology and Hepatology 2021
Bacterial Diversity Correlates with Overall Survival in Cancers of the Head and Neck, Liver, and Stomach.
Rodriguez RM, Menor M, Hernandez BY, Deng Y, Khadka VS
Molecules (Basel, Switzerland) 2021
Tumor-Associated Microbiome: Where Do We Stand?
Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V
International journal of molecular sciences 2021
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Chau J, Yadav M, Liu B, Furqan M, Dai Q, Shahi S, Gupta A, Mercer KN, Eastman E, Hejleh TA, Chan C, Weiner GJ, Cherwin C, Lee ST, Zhong C, Mangalam A, Zhang J
BMC Cancer 2021
Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
Steyger PS
American Journal of Audiology 2021
The role of a mechanistic host in maintaining arctic rabies variant distributions: Assessment of functional genetic diversity in Alaskan red fox (Vulpes vulpes).
Baecklund TM, Morrison J, Donaldson ME, Hueffer K, Kyle CJ
PloS one 2021
Machine Learning as a Tool in Investigating the Possible Role of Microbiome in Development and Treatment of Cancer
Hajeebu S, Ngembus NJ, Bandi PS, Panigrahy PK, Heindl S
Cureus 2021
Gastrointestinal cancers: the role of microbiota in carcinogenesis and the role of probiotics and microbiota in anti-cancer therapy efficacy.
Kaźmierczak-Siedlecka K, Ruszkowski J, Skonieczna-Żydecka K, Jędrzejczak J, Folwarski M, Makarewicz W
2021
The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review
Araji G, Maamari J, Ahmad FA, Zareef R, Chaftari P, Yeung SC
2021
IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors
HM Knochelmann, CJ Dwyer, AS Smith, JS Bowers, MM Wyatt, MH Nelson, GO Rivera, JD Horton, C Krieg, K Armeson, GB Lesinski, MP Rubinstein, Z Li, CM Paulos
Cancer research 2020
Reactive Myelopoiesis and the Onset of Myeloid-Mediated Immune Suppression: Implications for Adoptive Cell Therapy
P Innamarato, S Pilon-Thomas
Cellular Immunology 2020
Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response
S Bagheri, ES Qamsari, M Yousefi, F Riazi-Rad, Z Sharifzadeh
Cellular & Molecular Biology Letters 2020
Microbiome dysbiosis in lung cancer: from composition to therapy
NN Liu, Q Ma, Y Ge, CX Yi, LQ Wei, JC Tan, Q Chu, JQ Li, P Zhang, H Wang
npj Precision Oncology 2020
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
D Dutta, SH Lim
Biomarker Research 2020
Circulation of gut-preactivated naïve CD8 + T cells enhances antitumor immunity in B cell-defective mice
M Akrami, R Menzies, K Chamoto, M Miyajima, R Suzuki, H Sato, A Nishii, M Tomura, S Fagarasan, T Honjo
Proceedings of the National Academy of Sciences 2020
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
M Puccetti, S Xiroudaki, M Ricci, S Giovagnoli
Pharmaceutics 2020
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
S Anfossi, GA Calin
2020
Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare
R Zhang, , H Bai, K Ning
Frontiers in pharmacology 2020
Microbes and Cancer: Friends or Faux?
MM Azevedo, C Pina-Vaz, F Baltazar
International journal of molecular sciences 2020
Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
G Plavc, T Jesenko, M Oražem, P Strojan
Cancers 2020
The liver as an immunological barrier redefined by single‐cell analysis
Z Stamataki, L Swadling
Immunology 2020
The human gastrointestinal microbiota and prostate cancer development and treatment
S Sha, L Ni, M Stefil, M Dixon, V Mouraviev
Investigative and Clinical Urology 2020
Resveratrol and the Interaction between Gut Microbiota and Arterial Remodelling
AW Man, H Li, N Xia
Nutrients 2020
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer
S Li, Y Simoni, E Becht, CY Loh, N Li, D Lachance, SL Koo, TP Lim, EK Tan, R Mathew, A Nguyen, J Golovato, JD Berkson, M Prlic, B Lee, SS Minot, N Nagarajan, N Dey, DS Tan, IB Tan, EW Newell
Reproduction 2020
The landscape of bacterial presence in tumor and adjacent normal tissue across 9 major cancer types using TCGA exome sequencing
RM Rodriguez, BY Hernandez, M Menor, Y Deng, VS Khadka
Computational and Structural Biotechnology Journal 2020
Probiotics Can Boost the Antitumor Immunity of CD8 + T Cells in BALB/c Mice and Patients with Colorectal Carcinoma
J Mao, SZ Zhang, P Du, ZB Cheng, H Hu, SY Wang
Journal of Immunology Research 2020
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF
Clinical cancer research 2020
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway.
Xu X, Lv J, Guo F, Li J, Jia Y, Jiang D, Wang N, Zhang C, Kong L, Liu Y, Zhang Y, Lv J, Li Z
Frontiers in microbiology 2020
Microbiota in cancer chemoradiotherapy resistance
He Y, Liu QW, Liao HX, Xu WW
Clinical and Translational Medicine 2020
Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma
Ketpueak T, Thiennimitr P, Apaijai N, Chattipakorn SC, Chattipakorn N
Clinical and Translational Gastroenterology 2020
Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review.
Miller PL, Carson TL
Gut pathogens 2020
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Zhang X, Liu Q, Liao Q, Zhao Y
Journal of Cancer 2020
提高过继性T细胞免疫治疗临床疗效的新思考----肠道菌群与肿瘤免疫
任 军, 杨 朵
2020
The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer
Chen C, Li H
Journal of Microbiology and Biotechnology 2020
Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced anti-tumor immune response
Mireia Uribe-Herranz, Stavros Rafail, Silvia Beghi, Luis Gil-de-Gómez, Ioannis Verginadis, Kyle Bittinger, Sergey Pustylnikov, Stefano Pierini, Renzo Perales-Linares, Ian A Blair, Clementina Mesaros, Nathaniel W Snyder, Frederic Bushman, Constantinos Koumenis, Andrea Facciabene
Journal of Clinical Investigation 2019
Developing neoantigen-targeted T cell–based treatments for solid tumors
TN Yamamoto, RJ Kishton, NP Restifo
Nature Medicine 2019
Biomarkers for Immunotherapy of Cancer: Methods and Protocols
M Thurin, A Cesano, FM Marincola
2019
Gut microbiome and CAR-T therapy
MB Abid, NN Shah, TC Maatman, PN Hari
Experimental Hematology and Oncology 2019
Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
PH Lee, TN Yamamoto, D Gurusamy, M Sukumar, Z Yu, J Hu-Li, T Kawabe, A Gangaplara, RJ Kishton, AN Henning, SK Vodnala, RN Germain, WE Paul, NP Restifo
Journal of Experimental Medicine 2019
Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells
YQ Xie, H Arik, L Wei, Y Zheng, H Suh, DJ Irvine, L Tang
Biomaterials Science 2019
Host tissue determinants of tumour immunity
H Salmon, R Remark, S Gnjatic, M Merad
Nature Reviews Cancer 2019
Innate lymphoid cells: A potential link between microbiota and immune responses against cancer
SK Panda, M Colonna
Seminars in Immunology 2019
Gut Microbiota and Cancer: From Pathogenesis to Therapy
S Vivarelli, R Salemi, S Candido, L Falzone, M Santagati, S Stefani, F Torino, G Banna, G Tonini, M Libra
Cancers 2019
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Q Ma, C Xing, W Long, HY Wang, Q Liu, RF Wang
Journal of Neuroinflammation 2019
Exploring the emerging role of the microbiome in cancer immunotherapy
J Fessler, V Matson, TF Gajewski
Journal for ImmunoTherapy of Cancer 2019
The Human Microbiota and Prostate Cancer: Friend or Foe?
F Massari, V Mollica, VD Nunno, L Gatto, M Santoni, M Scarpelli, A Cimadamore, A Lopez-Beltran, L Cheng, N Battelli, R Montironi, G Brandi
Cancers 2019
Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice
K Arakawa, T Ishigami, M Nakai-Sugiyama, L Chen, H Doi, T Kino, S Minegishi, S Saigoh-Teranaka, R Sasaki-Nakashima, K Hibi, K Kimura, K Tamura, M Bader
PloS one 2019
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
R Villéger, A Lopès, G Carrier, J Veziant, E Billard, N Barnich, J Gagnière, E Vazeille, M Bonnet
International journal of molecular sciences 2019
Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade
N Marshall, K Hutchinson, TU Marron, M Aleynick, L Hammerich, R Upadhyay, J Svensson-Arvelund, BD Brown, M Merad, JD Brody
Cancer Discovery 2019
Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer.
Katayama Y, Yamada T, Tanimura K, Yoshimura A, Takeda T, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K
Thoracic Cancer 2019
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR
Advances in cancer research 2019
Therapeutic effects of iNOS inhibition against vitiligo in an animal model.
Mansourpour H, Ziari K, Motamedi SK, Poor AH
European Journal of Translational Myology 2019
Antibiotic therapy and outcome from immune-checkpoint inhibitors
Pinato DJ, Gramenitskaya D, Altmann DM, Boyton RJ, Mullish BH, Marchesi JR, Bower M
Journal for ImmunoTherapy of Cancer 2019
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe-Herranz, Kyle Bittinger, Stavros Rafail, Sonia Guedan, Stefano Pierini, Ceylan Tanes, Alex Ganetsky, Mark A Morgan, Saar Gill, Janos L. Tanyi, Frederic Bushman, Carl June, Andrea Facciabene
JCI Insight 2018
The Pharmacology of T Cell Therapies
MC Milone, VG Bhoj
Molecular Therapy — Methods & Clinical Development 2018
IL-2 and Beyond in Cancer Immunotherapy
JM Wrangle, A Patterson, CB Johnson, DJ Neitzke, S Mehrotra, CE Denlinger, CM Paulos, Z Li, DJ Cole, MP Rubinstein
Journal of Interferon & Cytokine Research 2018
Radiation effects on antitumor immune responses: current perspectives and challenges
T Walle, RM Monge, A Cerwenka, D Ajona, I Melero, F Lecanda
Therapeutic advances in medical oncology 2018
Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors
LK Ward-Kavanagh, KM Kokolus, TK Cooper, AE Lukacher, TD Schell
Cancer Immunology, Immunotherapy 2018
Gut microbiota injury in allogeneic haematopoietic stem cell transplantation
Y Shono, MR van Brink
Nature Reviews Cancer 2018
The clinical role of the TME in solid cancer
NA Giraldo, R Sanchez-Salas, JD Peske, Y Vano, E Becht, F Petitprez, P Validire, A Ingels, X Cathelineau, WH Fridman, C Sautès-Fridman
British Journal of Cancer 2018
Microbial markers in colorectal cancer detection and/or prognosis
R Villéger, A Lopès, J Veziant, J Gagnière, N Barnich, E Billard, D Boucher, M Bonnet
World journal of gastroenterology : WJG 2018
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
V Gopalakrishnan, BA Helmink, CN Spencer, A Reuben, JA Wargo
Cancer Cell 2018
Gut Microbiome and the Response to Immunotherapy in Cancer.
Stancu AL
2018
Pharmacologic inhibition of β-catenin and PI3Kδ paradoxically expands precursor Th17 cells with heightened stemness and antitumor activity
Kinga Majchrzak, Michelle H. Nelson, Jacob Bowers, Stefanie Bailey, Megan Meek, John Wrangle, Juan Varela, Mark Rubinstein, zihai Li, Richard Himes, Sherine Chan, Chrystal Paulos
JCI Insight 2017
Anticancer effects of the microbiome and its products
L Zitvogel, R Daillère, MP Roberti, B Routy, G Kroemer
Nature Reviews Microbiology 2017
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
C Fournier, F Martin, L Zitvogel, G Kroemer, L Galluzzi, L Apetoh
OncoImmunology 2017
Systematic evaluation of immune regulation and modulation
DF Stroncek, LH Butterfield, MA Cannarile, MV Dhodapkar, TF Greten, JC Grivel, DR Kaufman, HH Kong, F Korangy, PP Lee, F Marincola, S Rutella, JC Siebert, G Trinchieri, B Seliger
Journal for ImmunoTherapy of Cancer 2017
The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
MP Kuczma, ZC Ding, T Li, T Habtetsion, T Chen, Z Hao, L Bryan, N Singh, JN Kochenderfer, G Zhou
Oncotarget 2017
Stimulating Innate Immunity to Enhance Radiation Therapy–Induced Tumor Control
JR Baird, AM Monjazeb, O Shah, H McGee, WJ Murphy, MR Crittenden, MJ Gough
International journal of radiation oncology, biology, physics 2017
Immunotherapy of cancer: targeting cancer during active disease or during dormancy?
SA Shah, M Zarei, SH Manjili, G Guruli, XY Wang, MH Manjili
Immunotherapy 2017
In Vivo Murine-Matured Human CD3 + Cells as a Preclinical Model for T Cell-Based Immunotherapies
KG Haworth, C Ironside, ZK Norgaard, WM Obenza, JE Adair, HP Kiem
Molecular Therapy - Methods & Clinical Development 2017
Homeostatic Immunity and the Microbiota
Y Belkaid, OJ Harrison
Immunity 2017
Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
KM Hargadon
Frontiers in immunology 2017
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40
AE Foster, A Mahendravada, NP Shinners, WC Chang, J Crisostomo, A Lu, M Khalil, E Morschl, JL Shaw, S Saha, ML Duong, MR Collinson-Pautz, DL Torres, T Rodriguez, T Pentcheva-Hoang, JH Bayle, KM Slawin, DM Spencer
Molecular Therapy 2017
The influence of the commensal microbiota on distal tumor-promoting inflammation
CM Rosean, MR Rutkowski
Seminars in Immunology 2017
Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in mice
JS Carr, S King, CM Dekaney, SR Singh
PloS one 2017
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation
JU Peled, SM Devlin, A Staffas, M Lumish, R Khanin, ER Littmann, L Ling, S Kosuri, M Maloy, JB Slingerland, KF Ahr, KA Rodriguez, Y Shono, AE Slingerland, MD Docampo, AD Sung, D Weber, AM Alousi, B Gyurkocza, DM Ponce, JN Barker, MA Perales, SA Giralt, Y Taur, EG Pamer, RR Jenq, MR van Brink
Journal of Clinical Oncology 2017
Monitoring neonates for ototoxicity
AC Garinis, A Kemph, AM Tharpe, JH Weitkamp, C McEvoy, PS Steyger
International Journal of Audiology 2017
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, TV Karpinets, PA Prieto, D Vicente, K Hoffman, SC Wei, AP Cogdill, L Zhao, CW Hudgens, DS Hutchinson, T Manzo, MP de Macedo, T Cotechini, T Kumar, WS Chen, SM Reddy, RS Sloane, J Galloway-Pena, H Jiang, PL Chen, EJ Shpall, K Rezvani, AM Alousi, RF Chemaly, S Shelburne, LM Vence, PC Okhuysen, VB Jensen, AG Swennes, F McAllister, EM Sanchez, Y Zhang, EL Chatelier, L Zitvogel, N Pons, JL Austin-Breneman, LE Haydu, EM Burton, JM Gardner, E Sirmans, J Hu, AJ Lazar, T Tsujikawa, A Diab, H Tawbi, IC Glitza, WJ Hwu, SP Patel, SE Woodman, RN Amaria, MA Davies, JE Gershenwald, P Hwu, JE Lee, J Zhang, LM Coussens, ZA Cooper, PA Futreal, CR Daniel, NJ Ajami, JF Petrosino, MT Tetzlaff, P Sharma, JP Allison, RR Jenq, JA Wargo
Science 2017
Unlocking the Complex Flavors of Dysgeusia after Hematopoietic Cell Transplantation
Scordo M, Shah G, Peled JU, Preston E, Buchan M, Epstein JB, Barasch A, Giralt S
Biology of Blood and Marrow Transplantation 2017
Origins of cancer: tackling provocative questions
Solitro AR, Vander Schaaf NA
Genes & cancer 2017
Gut microbiota and immune crosstalk in metabolic disease
R Burcelin
Molecular Metabolism 2016
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
MH Nelson, JS Bowers, SR Bailey, MA Diven, CW Fugle, AD Kaiser, C Wrzesinski, B Liu, NP Restifo, CM Paulos
Journal for ImmunoTherapy of Cancer 2016
Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model
T Suzuki, H Kishimoto, R Abe
Cancer Immunology, Immunotherapy 2016
Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239
LT Zhang, RR Tian, HY Zheng, GQ Pan, XY Tuo, HJ Xia, XS Xia, W Pang, YT Zheng
Immunology 2016
Adapting Cancer Immunotherapy Models for the Real World
LE Klevorn, RM Teague
Trends in Immunology 2016
Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8 + T-cell response
ML Salem, M Nassef, SG Salam, A Zidan, MH Mahmoud, G Badr, M Rubinstein, D Cole
Journal of Immunotoxicology 2016
The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy
J Chacon, K Schutsky, D Powell
Human vaccines 2016
Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion
SM Anthony, SC Rivas, SL Colpitts, ME Howard, SW Stonier, KS Schluns
Journal of immunology (Baltimore, Md. : 1950) 2016
The Basis of Oncoimmunology
AK Palucka, LM Coussens
Cell 2016
The role of microbiota in cancer therapy
E Perez-Chanona, G Trinchieri
Current Opinion in Immunology 2016
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
CY Slaney, B von Scheidt, AJ Davenport, PA Beavis, JA Westwood, S Mardiana, DC Tscharke, S Ellis, HM Prince, JA Trapani, RW Johnstone, MJ Smyth, MW Teng, A Ali, Z Yu, SA Rosenberg, NP Restifo, P Neeson, PK Darcy, MH Kershaw
Clinical cancer research 2016
Microbiota-myeloid cell crosstalk beyond the gut.
Gorjifard S, Goldszmid RS
Journal of leukocyte biology 2016
T-cell receptor gene therapy - ready to go viral?
T Karpanen, J Olweus
Molecular Oncology 2015
Rapid Functional Decline of Activated and Memory Graft-versus-Host-Reactive T Cells Encountering Host Antigens in the Absence of Inflammation
HW Li, G Andreola, AL Carlson, S Shao, CP Lin, G Zhao, M Sykes
Journal of immunology (Baltimore, Md. : 1950) 2015
Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth
J Lévy, W Cacheux, MA Bara, A L’Hermitte, P Lepage, M Fraudeau, C Trentesaux, J Lemarchand, A Durand, AM Crain, C Marchiol, G Renault, F Dumont, F Letourneur, M Delacre, A Schmitt, B Terris, C Perret, M Chamaillard, JP Couty, B Romagnolo
Nature Cell Biology 2015
Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
JS Bowers, MH Nelson, S Kundimi, SR Bailey, LW Huff, KM Schwartz, DJ Cole, MP Rubinstein, CM Paulos
Clinical cancer research 2015
Harnessing the Microbiome to Enhance Cancer Immunotherapy
MH Nelson, MA Diven, LW Huff, CM Paulos
Journal of Immunology Research 2015
Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice
G Espinosa-Carrasco, M Villard, CL Saout, P Louis-Plence, R Vicente, J Hernandez, H Shiku
PloS one 2015
Adoptive cell transfer as personalized immunotherapy for human cancer
SA Rosenberg, NP Restifo
Science 2015
Genetically modified T cells in cancer therapy: opportunities and challenges
M Sharpe, N Mount
Disease models & mechanisms 2015
Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma
N Lendvai, AD Cohen, HJ Cho
Bone Marrow Transplantation 2015
Microbiota Modulation of Myeloid Cells in Cancer Therapy
RS Goldszmid, A Dzutsev, S Viaud, L Zitvogel, NP Restifo, G Trinchieri
Cancer immunology research 2015
Radiation takes its Toll
JA Ratikan, ED Micewicz, MW Xie, D Schaue
Cancer Letters 2015
The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue
MH Nelson, S Kundimi, JS Bowers, CE Rogers, LW Huff, KM Schwartz, K Thyagarajan, EC Little, S Mehrotra, DJ Cole, MP Rubinstein, CM Paulos
Journal of immunology (Baltimore, Md. : 1950) 2015
Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner
T Bald, J Landsberg, P Jansen, E Gaffal, T Tüting
OncoImmunology 2015
Cancer Immunity: Lessons From Infectious Diseases
G Trinchieri
The Journal of Infectious Diseases 2015
Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
OJ Harrison, N Srinivasan, J Pott, C Schiering, T Krausgruber, NE Ilott, KJ Maloy
Mucosal Immunology 2015
Cancer and the gut microbiota: An unexpected link
L Zitvogel, L Galluzzi, S Viaud, M Vetizou, R Daillere, M Merad, G Kroemer
Science Translational Medicine 2015
SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
S Fernandes, R Brooks, M Gumbleton, MY Park, CM Russo, KT Howard, JD Chisholm, WG Kerr
EBioMedicine 2015
Depletion of B220 + NK1.1 + cells enhances the rejection of established melanoma by tumor-specific CD4 + T cells
KA Wilson, SR Goding, HR Neely, KM Harris, PA Antony
OncoImmunology 2015
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy
M Blanchard, KG Shim, MP Grams, K Rajani, RM Diaz, KM Furutani, J Thompson, KR Olivier, SS Park, SN Markovic, H Pandha, A Melcher, K Harrington, S Zaidi, R Vile
International journal of radiation oncology, biology, physics 2015
Toxicities Associated With Adoptive T-Cell Transfer for Cancer:
JC Yang
The Cancer Journal 2015
Short Course in the Microbiome
K Falana, R Knight, CR Martin, R Goldszmid, KL Greathouse, J Gere, H Young, WP Kuo
Journal of Circulating Biomarkers 2015
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy
DS Chung, HJ Shin, YK Hong
Journal of Immunology Research 2014
Role of the Microbiota in Immunity and Inflammation
Y Belkaid, TW Hand
Cell 2014
Novel immunotherapies for hematologic malignancies
MH Nelson, CM Paulos
Immunological Reviews 2014
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
E Romano, O Michielin, V Voelter, J Laurent, H Bichat, A Stravodimou, P Romero, DE Speiser, F Triebel, S Leyvraz, A Harari
Journal of Translational Medicine 2014
Th17 Cells in Cancer: The Ultimate Identity Crisis
SR Bailey, MH Nelson, RA Himes, Z Li, S Mehrotra, CM Paulos
Frontiers in immunology 2014
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing
Y Ji, N Abrams, W Zhu, E Salinas, Z Yu, DC Palmer, P Jailwala, Z Franco, R Roychoudhuri, E Stahlberg, L Gattinoni, NP Restifo
PloS one 2014
Whole-Body Irradiation Increases the Magnitude and Persistence of Adoptively Transferred T Cells Associated with Tumor Regression in a Mouse Model of Prostate Cancer
LK Ward-Kavanagh, J Zhu, TK Cooper, TD Schell
Cancer immunology research 2014
Radiation as immunomodulator: implications for dendritic cell-based immunotherapy
RE Roses, J Datta, BJ Czerniecki
Radiation Research 2014
T-Cell Immunotherapy: Looking Forward
J Corrigan-Curay, HP Kiem, D Baltimore, M O'Reilly, RJ Brentjens, L Cooper, S Forman, S Gottschalk, P Greenberg, R Junghans, H Heslop, M Jensen, C Mackall, C June, O Press, D Powell, A Ribas, S Rosenberg, M Sadelain, B Till, AP Patterson, RC Jambou, E Rosenthal, L Gargiulo, M Montgomery, DB Kohn
Molecular Therapy 2014
miR-155 augments CD8 + T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γ c cytokines
Y Ji, C Wrzesinski, Z Yu, J Hu, S Gautam, NV Hawk, WG Telford, DC Palmer, Z Franco, M Sukumar, R Roychoudhuri, D Clever, CA Klebanoff, CD Surh, TA Waldmann, NP Restifo, L Gattinoni
2014
Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors
EM Cozza, TK Cooper, LR Budgeon, ND Christensen, TD Schell
Cancer Immunology, Immunotherapy 2014
Host Immune Response to Infection and Cancer: Unexpected Commonalities
RS Goldszmid, A Dzutsev, G Trinchieri
Cell Host & Microbe 2014
Current advances in T-cell-based cancer immunotherapy
M Wang, B Yin, HY Wang, RF Wang
Immunotherapy 2014
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
SC Wagner, B Markosian, N Ajili, BR Dolan, AJ Kim, DT Alexandrescu, CA Dasanu, B Minev, J Koropatnick, FM Marincola, NH Riordan
Journal of Translational Medicine 2014
Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
M Piesche, VT Ho, H Kim, Y Nakazaki, M Nehil, NK Yaghi, D Kolodin, J Weiser, P Altevogt, H Kiefel, EP Alyea, JH Antin, C Cutler, J Koreth, C Canning, J Ritz, RJ Soiffer, G Dranoff
Clinical cancer research 2014
Harnessing the Intestinal Microbiome for Optimal Therapeutic Immunomodulation
S Viaud, R Daillere, IG Boneca, P Lepage, MJ Pittet, F Ghiringhelli, G Trinchieri, R Goldszmid, L Zitvogel
Cancer research 2014
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells
CA Klebanoff, SP Spencer, P Torabi-Parizi, JR Grainger, R Roychoudhuri, Y Ji, M Sukumar, P Muranski, CD Scott, JA Hall, GA Ferreyra, AJ Leonardi, ZA Borman, J Wang, DC Palmer, C Wilhelm, R Cai, J Sun, JL Napoli, RL Danner, L Gattinoni, Y Belkaid, NP Restifo
Journal of Experimental Medicine 2013
EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
JH Sampson, BD Choi, L Sanchez-Perez, CM Suryadevara, DJ Snyder, CT Flores, RJ Schmittling, SK Nair, EA Reap, PK Norberg, JE Herndon, CT Kuan, RA Morgan, SA Rosenberg, LA Johnson
Clinical cancer research 2013
Exploiting the curative potential of adoptive T-cell therapy for cancer
CS Hinrichs, SA Rosenberg
Immunological Reviews 2013
Reassessing target antigens for adoptive T-cell therapy
CS Hinrichs, NP Restifo
Nature Biotechnology 2013
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line
JJ Parker, JC Jones, S Strober, SJ Knox
Clinical Immunology 2013
Immune surveillance by the liver
CN Jenne, P Kubes
Nature Immunology 2013
A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance
C Liu, C Zhang, RE Mitchel, J Cui, J Lin, Y Yang, X Liu, J Cai
Cell Death and Disease 2013
Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors
NM Lerret, AL Marzo
OncoImmunology 2013
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
N Iida, A Dzutsev, CA Stewart, L Smith, N Bouladoux, RA Weingarten, DA Molina, R Salcedo, T Back, S Cramer, RM Dai, H Kiu, M Cardone, S Naik, AK Patri, E Wang, FM Marincola, KM Frank, Y Belkaid, G Trinchieri, RS Goldszmid
Science 2013
Polyarginine Induces an Antitumor Immune Response through Binding to Toll-Like Receptor 4
Y Yang, J Wolfram, X Fang, H Shen, M Ferrari
Small 2013
The Past, Present, and Future of Adoptive T Cell Therapy
D Choi, TG Kim, YC Sung
Immune Network 2012
Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors
NM Lerret, M Rogozinska, A Jaramillo, AL Marzo
PloS one 2012
Adoptive Immunotherapy of Advanced Melanoma
R Shapira-Frommer, J Schachter
Current Treatment Options in Oncology 2012
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
DW Lee, DM Barrett, C Mackall, R Orentas, SA Grupp
Clinical cancer research 2012
Adoptive immunotherapy for cancer: harnessing the T cell response
NP Restifo, ME Dudley, SA Rosenberg
Nature Reviews Immunology 2012
The role of innate immune signals in antitumor immunity
M Jinushi
OncoImmunology 2012
Tumor-Infiltrating Lymphocytes in Melanoma
S Lee, K Margolin
Current Oncology Reports 2012
Emerging concepts in haematopoietic cell transplantation
HW Li, M Sykes
Nature Reviews Immunology 2012
Adoptive Transfer of Cytotoxic T Lymphocytes Targeting Two Different Antigens Limits Antigen Loss and Tumor Escape
KM Kaluza, T Kottke, RM Diaz, D Rommelfanger, J Thompson, R Vile
Human Gene Therapy 2012
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman, GH Imperato, TF Tedder, M Sadelain, RJ Brentjens
Blood 2012
Human Tumor Xenografts: The Good, the Bad, and the Ugly
RA Morgan
Molecular Therapy 2012
An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2RγNULL Mice Allows HIV Replication and Development of Anti-HIV Immune Responses
M Singh, P Singh, G Gaudray, L Musumeci, C Thielen, D Vaira, C Vandergeeten, L Delacroix, EV Gulck, G Vanham, L Leval, S Rahmouni, M Moutschen
PloS one 2012
Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras
H Wang, Y Yang, G Wang, S Wang, BY Yeap, M Sykes, YG Yang
PloS one 2012
Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activation
Y Zhou, H Ni, M Li, JK Sanzari, ES Diffenderfer, L Lin, AR Kennedy, D Weissman
PloS one 2012
A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy
HI Cho, E Reyes-Vargas, JC Delgado, E Celis
Cancer research 2012
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
DM Rommelfanger, MC Grau, RM Diaz, E Ilett, L Alvarez-Vallina, JM Thompson, TJ Kottke, A Melcher, RG Vile
Molecular Therapy 2012
Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles
JI Pearl, T Ma, AR Irani, Z Huang, WH Robinson, RL Smith, SB Goodman
Biomaterials 2011
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
J Amar, C Chabo, A Waget, P Klopp, C Vachoux, LG Bermúdez-Humarán, N Smirnova, M Bergé, T Sulpice, S Lahtinen, A Ouwehand, P Langella, N Rautonen, PJ Sansonetti, R Burcelin
EMBO Molecular Medicine 2011
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
SA Quezada, KS Peggs, TR Simpson, JP Allison
Immunological Reviews 2011
Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
A Oblak, R Jerala
Clinical and Developmental Immunology 2011
Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
SA Rosenberg
Nature Reviews Clinical Oncology 2011
Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation
H Ni, K Balint, Y Zhou, DS Gridley, C Maks, AR Kennedy, D Weissman
Radiation Research 2011
Selective Resistance of CD44 hi T Cells to p53-Dependent Cell Death Results in Persistence of Immunologic Memory after Total Body Irradiation
Z Yao, J Jones, H Kohrt, S Strober
Journal of immunology (Baltimore, Md. : 1950) 2011
New perspectives on the role of vitiligo in immune responses to melanoma.
Byrne KT, Turk MJ
Oncotarget 2011
Tumor destruction and spontaneous autoimmunity following long-term lentiviral CD4+ TCR gene-modified HSC transplantation in mice
Sung Ha, Nicholas Klemen, Garrett Kinnebrew, Andrew Brandmaier, Jon Marsh, Giao Hangoc, Douglas Palmer, Nicholas Restifo, Ken Cornetta, Hal E. Broxmeyer, Christopher Touloukian
Journal of Clinical Investigation 2010
Amplifying TLR-MyD88 signals within tumor-specific T-cells enhances antitumor activity to suboptimal levels of weakly-immunogenic tumor-antigens
D Geng, L Zheng, R Srivastava, C Velasco-Gonzalez, A Riker, SN Markovic, E Davila
Cancer research 2010
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Y Xie, A Akpinarli, C Maris, EL Hipkiss, M Lane, EK Kwon, P Muranski, NP Restifo, PA Antony
Journal of Experimental Medicine 2010
Therapeutic cancer vaccines: are we there yet?
CA Klebanoff, N Acquavella, Z Yu, NP Restifo
Immunological Reviews 2010
IL-2 Mediates CD4+ T Cell Help in the Breakdown of Memory-Like CD8+ T Cell Tolerance under Lymphopenic Conditions
CL Saout, M Villard, C Cabasse, C Jacquet, N Taylor, J Hernandez, D Unutmaz
PloS one 2010
Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo
ML Salem, SA El-Naggar, DJ Cole
Cellular Immunology 2010
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
C Wrzesinski, CM Paulos, A Kaiser, P Muranski, DC Palmer, L Gattinoni, Z Yu, SA Rosenberg, NP Restifo
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
DA Hill, D Artis
Annual Review of Immunology 2010
Toll-like receptor agonists: are they good adjuvants?
S Gnjatic, NB Sawhney, N Bhardwaj
Cancer journal (Sudbury, Mass.) 2010
The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model
J Fang, D Fang, PB Silver, F Wen, B Li, X Ren, Q Lin, RR Caspi, SB Su
Investigative ophthalmology & visual science 2010
Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells
ML Salem, AA Al-Khami, SA El-Naggar, CM Díaz-Montero, Y Chen, DJ Cole
Journal of immunology (Baltimore, Md. : 1950) 2010
Redirecting the Immune Response: Role of Adoptive T Cell Therapy
A Mondino, V Dardalhon, RH Michelini, S Loisel-Meyer, N Taylor
Human Gene Therapy 2010
Tumor-Specific CD8 + T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
SP Kerkar, P Muranski, A Kaiser, A Boni, L Sanchez-Perez, Z Yu, DC Palmer, RN Reger, ZA Borman, L Zhang, RA Morgan, L Gattinoni, SA Rosenberg, G Trinchieri, NP Restifo
Cancer research 2010
CD8+ enriched “young” tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
ME Dudley, CA Gross, MM Langhan, MR Garcia, RM Sherry, JC Yang, GQ Phan, US Kammula, MS Hughes, DE Citrin, NP Restifo, JR Wunderlich, PA Prieto, JJ Hong, RC Langan, DA Zlott, KE Morton, DE White, CM Laurencot, SA Rosenberg
Clinical cancer research 2010
Putting the brakes on BTLA in T cell–mediated cancer immunotherapy
Chrystal M. Paulos, Carl H. June
Journal of Clinical Investigation 2009
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
GA Rizzuto, T Merghoub, D Hirschhorn-Cymerman, C Liu, AM Lesokhin, D Sahawneh, H Zhong, KS Panageas, MA Perales, G Altan-Bonnet, JD Wolchok, AN Houghton
Journal of Experimental Medicine 2009
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
Y Cui, H Zhang, J Meadors, R Poon, M Guimond, CL Mackall
Blood 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function
DC Palmer, NP Restifo
Trends in Immunology 2009
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination
ML Salem, DJ Cole
Cancer Immunology, Immunotherapy 2009
Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)
ML Salem, CM Díaz-Montero, AA Al-Khami, SA El-Naggar, O Naga, AJ Montero, A Khafagy, DJ Cole
Journal of immunology (Baltimore, Md. : 1950) 2009
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
V Radojcic, KB Bezak, M Skarica, MA Pletneva, K Yoshimura, RD Schulick, L Luznik
Cancer Immunology, Immunotherapy 2009
Toll-like receptor agonists in cancer therapy
S Adams
Immunotherapy 2009
Adoptive cell therapy for the treatment of patients with metastatic melanoma
SA Rosenberg, ME Dudley
Current Opinion in Immunology 2009
Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma
C Geiger, E Nößner, B Frankenberger, CS Falk, H Pohla, DJ Schendel
Journal of Molecular Medicine 2009
Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation
A Filatenkov, AM Müller, WW Tseng, S Dejbakhsh-Jones, D Winer, R Luong, JA Shizuru, EG Engleman, S Strober
Journal of immunology (Baltimore, Md. : 1950) 2009
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation
VT Ho, M Vanneman, H Kim, T Sasada, YJ Kang, M Pasek, C Cutler, J Koreth, E Alyea, S Sarantopoulos, JH Antin, J Ritz, C Canning, J Kutok, MC Mihm, G Dranoff, R Soiffer
Proceedings of the National Academy of Sciences 2009
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
PD Cani, S Possemiers, TV de Wiele, Y Guiot, A Everard, O Rottier, L Geurts, D Naslain, A Neyrinck, DM Lambert, GG Muccioli, NM Delzenne
Gut 2009
The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis:
MC Abt, D Artis
Current Opinion in Gastroenterology 2009
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors
JD Brody, MJ Goldstein, DK Czerwinski, R Levy
Blood 2009
An Essential Role of the Forkhead-Box Transcription Factor Foxo1 in Control of T Cell Homeostasis and Tolerance
W Ouyang, O Beckett, RA Flavell, MO Li
Immunity 2009
Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy
G Verdeil, K Marquardt, CD Surh, LA Sherman
Proceedings of the National Academy of Sciences 2008
From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
DC Palmer, CC Chan, L Gattinoni, C Wrzesinski, CM Paulos, CS Hinrichs, DJ Powell, CA Klebanoff, SE Finkelstein, RN Fariss, Z Yu, RB Nussenblatt, SA Rosenberg, NP Restifo
Proceedings of the National Academy of Sciences 2008
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
N Asprodites, L Zheng, D Geng, C Velasco-Gonzalez, L Sanchez-Perez, E Davila
The FASEB Journal 2008
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
SA Quezada, KS Peggs, TR Simpson, Y Shen, DR Littman, JP Allison
Journal of Experimental Medicine 2008
The nature of the lymphopenic environment dictates protective function of homeostatic-memory CD8+ T cells
SE Hamilton, SC Jameson
Proceedings of the National Academy of Sciences 2008
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
SA Rosenberg, NP Restifo, JC Yang, RA Morgan, ME Dudley
Nature reviews. Cancer 2008
Immunotherapy for Advanced Melanoma
L Fang, AS Lonsdorf, ST Hwang
Journal of Investigative Dermatology 2008
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers
A Boni, P Muranski, L Cassard, C Wrzesinski, CM Paulos, DC Palmer, L Gattinoni, CS Hinrichs, CC Chan, SA Rosenberg, NP Restifo
Blood 2008
Dendritic cells: a critical player in cancer therapy?
AK Palucka, H Ueno, J Fay, J Banchereau
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008
Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
A Wallace, V Kapoor, J Sun, P Mrass, W Weninger, DF Heitjan, C June, LR Kaiser, LE Ling, SM Albelda
Clinical cancer research 2008
Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses
JA Hall, N Bouladoux, CM Sun, EA Wohlfert, RB Blank, Q Zhu, ME Grigg, JA Berzofsky, Y Belkaid
Immunity 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, PF Robbins, JP Huang, DE Citrin, SF Leitman, J Wunderlich, NP Restifo, A Thomasian, SG Downey, FO Smith, J Klapper, K Morton, C Laurencot, DE White, SA Rosenberg
Journal of Clinical Oncology 2008
CD8+ T Cells Targeting A Single Immunodominant Epitope Are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors
Tatum AM, Mylin LM, Bender SJ, Fischer MA, Vigliotti BA, Tevethia MJ, Tevethia SS, Schell TD
Journal of immunology (Baltimore, Md. : 1950) 2008
Toll-like receptors in tumor immunotherapy
CM Paulos, A Kaiser, C Wrzesinski, CS Hinrichs, L Cassard, A Boni, P Muranski, L Sanchez-Perez, DC Palmer, Z Yu, PA Antony, L Gattinoni, SA Rosenberg, NP Restifo
Clinical cancer research 2007

← Previous 1 2 3 … 12 13 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Blogged by 2
Posted by 4 X users
Referenced in 10 patents
243 readers on Mendeley
See more details